For Immediate Release Contact marketingcommunications@us.medical.canon
January 15, 2008
Notice to our customers and colleagues:
On December 13, 2007, the Centers for Medicare and Medicaid Services (CMS) proposed a change to the way coronary CTA is reimbursed under Medicare. CMS’s proposed National Coverage Decision would eliminate all Medicare reimbursement for coronary CTA except for two indications and further stipulated that coronary CTA must be performed within a controlled clinical trial to be reimbursed. The final decision will be made in March of this year.
As is always the case during industry events like this, Toshiba America Medical Systems is participating in several activities in response to this action:
For those seeking more information, here are web links on this topic and other related issues: